The University of Chicago Header Logo

Connection

Michael Becker to Lupus Erythematosus, Systemic

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Lupus Erythematosus, Systemic.
Michael Becker
Connection Strength
0.068
Lupus Erythematosus, Systemic
  1. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther. 2008; 10(5):R109.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.